iRhythm Holdings, Inc. Increase (Decrease) in Accrued Liabilities
iRhythm Holdings, Inc. (IRTC) reported Increase (Decrease) in Accrued Liabilities of $19.30 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2024-02-22
- iRhythm Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2023-12-31 was $8.39M, a 31.04% increase year-over-year.
- iRhythm Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2023-09-30 was $12.18M, a 30.30% increase year-over-year.
- iRhythm Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2023-06-30 was $9.96M, a 22.14% increase year-over-year.
- iRhythm Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2023-03-31 was -$11.23M.
- iRhythm Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $19.30M, a 33.34% increase from fiscal 2022.
- iRhythm Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $14.47M, a 82.14% increase from fiscal 2021.
- iRhythm Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2021 was $7.95M, a 507.49% increase from fiscal 2020.
- iRhythm Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2020 was $1.31M, a 78.21% decline from fiscal 2019.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $8.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $20.57M derived: sum of 2 quarters · filed 2024-02-22 | $30.53M derived: sum of 3 quarters · filed 2024-02-22 | $19.30M 10-K · filed 2024-02-22 | ||||
| 2023-09-30 | $12.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $22.14M derived: sum of 2 quarters · filed 2023-11-02 | $10.91M 10-Q · filed 2023-11-02 | $17.31M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2023-06-30 | $9.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$1.27M 10-Q · filed 2023-08-04 | $5.13M derived: sum of 3 quarters · filed 2024-02-22 | $14.48M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2023-03-31 | -$11.23M 10-Q · filed 2023-05-04 | -$4.83M derived: sum of 2 quarters · filed 2024-02-22 | $4.52M derived: sum of 3 quarters · filed 2024-02-22 | $12.67M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $15.75M derived: sum of 2 quarters · filed 2024-02-22 | $23.90M derived: sum of 3 quarters · filed 2024-02-22 | $14.47M 10-K · filed 2024-02-22 | ||||
| 2022-09-30 | $9.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $17.50M derived: sum of 2 quarters · filed 2023-11-02 | $8.07M 10-Q · filed 2023-11-02 | $4.68M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $8.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$1.28M 10-Q · filed 2023-08-04 | -$4.67M derived: sum of 3 quarters · filed 2024-02-22 | $8.65M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | -$9.43M 10-Q · filed 2023-05-04 | -$12.82M derived: sum of 2 quarters · filed 2024-02-22 | $502.00K derived: sum of 3 quarters · filed 2024-02-22 | $4.66M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | -$3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $9.93M derived: sum of 2 quarters · filed 2024-02-22 | $14.09M derived: sum of 3 quarters · filed 2024-02-22 | $7.95M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $13.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $17.48M derived: sum of 2 quarters · filed 2022-11-04 | $11.34M 10-Q · filed 2022-11-04 | $18.01M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $4.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$1.99M 10-Q · filed 2022-08-05 | $4.69M derived: sum of 3 quarters · filed 2023-02-23 | $9.01M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | -$6.14M 10-Q · filed 2022-05-06 | $533.00K derived: sum of 2 quarters · filed 2023-02-23 | $4.86M derived: sum of 3 quarters · filed 2023-02-23 | $4.63M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $11.00M derived: sum of 2 quarters · filed 2023-02-23 | $10.78M derived: sum of 3 quarters · filed 2023-02-23 | $1.31M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $4.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $4.10M derived: sum of 2 quarters · filed 2021-11-05 | -$5.37M 10-Q · filed 2021-11-05 | -$5.00M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | -$222.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$9.69M 10-Q · filed 2021-08-09 | -$9.32M derived: sum of 3 quarters · filed 2022-02-28 | -$430.00K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | -$9.47M 10-Q · filed 2021-05-10 | -$9.10M derived: sum of 2 quarters · filed 2022-02-28 | -$208.00K derived: sum of 3 quarters · filed 2022-02-28 | $2.60M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $367.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $9.26M derived: sum of 2 quarters · filed 2022-02-28 | $12.06M derived: sum of 3 quarters · filed 2022-02-28 | $6.00M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $8.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $11.70M derived: sum of 2 quarters · filed 2020-11-06 | $5.63M 10-Q · filed 2020-11-06 | $12.93M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$3.26M 10-Q · filed 2020-08-07 | -$3.19M 10-Q · filed 2019-08-06 | $4.03M derived: sum of 3 quarters · filed 2021-02-26 | $6.93M derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-03-31 | -$6.06M 10-Q · filed 2020-05-08 | -$6.38M 10-Q · filed 2019-05-10 | $1.23M derived: sum of 2 quarters · filed 2021-02-26 | $4.13M derived: sum of 3 quarters · filed 2021-02-26 | $7.66M derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2018-12-31 | $7.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $10.19M derived: sum of 2 quarters · filed 2021-02-26 | $13.72M derived: sum of 3 quarters · filed 2021-02-26 | $10.50M 10-K · filed 2021-02-26 | $10.78M 10-K · filed 2019-03-04 | |||
| 2018-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-12-23 | $6.43M derived: sum of 2 quarters · filed 2019-12-23 | $3.21M 10-Q · filed 2019-12-23 | $3.33M 10-Q · filed 2018-10-30 | $7.67M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $3.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-23 | $311.00K 10-Q · filed 2019-12-23 | $497.00K 10-Q · filed 2018-08-03 | $4.77M derived: sum of 3 quarters · filed 2020-03-02 | $5.85M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | -$3.22M 10-Q · filed 2019-12-23 | -$2.98M 10-Q · filed 2018-05-10 | $1.24M derived: sum of 2 quarters · filed 2020-03-02 | $2.31M derived: sum of 3 quarters · filed 2020-03-02 | $4.41M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $4.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $5.54M derived: sum of 2 quarters · filed 2020-03-02 | $7.63M derived: sum of 3 quarters · filed 2020-03-02 | $5.76M 10-K · filed 2020-03-02 | $5.36M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $3.17M derived: sum of 2 quarters · filed 2018-10-30 | $1.29M 10-Q · filed 2018-10-30 | $5.04M derived: sum of 4 quarters · filed 2019-03-04 | ||||
| 2017-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $219.00K 10-Q · filed 2018-08-03 | $3.96M derived: sum of 3 quarters · filed 2019-03-04 | $4.43M derived: sum of 4 quarters · filed 2019-03-04 | ||||
| 2017-03-31 | -$1.87M 10-Q · filed 2018-05-10 | $1.87M derived: sum of 2 quarters · filed 2019-03-04 | $2.33M derived: sum of 3 quarters · filed 2019-03-04 | $4.75M derived: sum of 4 quarters · filed 2019-03-04 | ||||
| 2016-12-31 | $3.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | $4.21M derived: sum of 2 quarters · filed 2019-03-04 | $6.62M derived: sum of 3 quarters · filed 2019-03-04 | $3.38M 10-K · filed 2019-03-04 | ||||
| 2016-09-30 | $464.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $2.88M derived: sum of 2 quarters · filed 2017-11-14 | -$363.00K 10-Q · filed 2017-11-14 | $1.11M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $2.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$827.00K 10-Q · filed 2017-08-07 | $649.00K derived: sum of 3 quarters · filed 2018-03-01 | |||||
| 2016-03-31 | -$3.24M 10-Q · filed 2017-05-12 | -$1.76M derived: sum of 2 quarters · filed 2018-03-01 | ||||||
| 2015-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $3.52M 10-K · filed 2018-03-01 | ||||||
| 2015-09-30 | $2.05M 10-Q · filed 2016-12-05 | |||||||
| 2014-12-31 | $1.40M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |